利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

13 条记录 (耗时 0.051 秒)

    Compounds of unstable DP IV-inhibitors
    2.
    发明授权
    Compounds of unstable DP IV-inhibitors 有权
    不稳定DP IV抑制剂的化合物

    公开(公告)号：US07053055B2

    公开(公告)日：2006-05-30

    申请号：US09745883

    申请日：2000-12-21

    申请人： Hans-Ulrich Demuth ,  Jorn Schmidt ,  Torsten Hoffmann ,  Konrad Glund

    发明人： Hans-Ulrich Demuth ,  Jorn Schmidt ,  Torsten Hoffmann ,  Konrad Glund

    IPC分类号： A61K38/06 ,  A61K38/07 ,  C07K5/00

    CPC分类号： C07K5/0808 ,  A61K38/00

    摘要： Novel compounds of unstable inhibitors of the serine peptidase dipeptidyl peptidase IV, are used in the treatment of various disorders, especially of metabolic disorders. The compounds can be used in the treatment of impaired glucose tolerance, glucosuria, hyperlipidaemia, metabolic acidoses, diabetes mellitus, diabetic neuropathy and nephropathy.

    摘要翻译： 丝氨酸肽酶二肽基肽酶IV的不稳定抑制剂的新型化合物用于治疗各种疾病，特别是代谢紊乱。 该化合物可用于治疗葡萄糖耐量异常，葡萄糖尿，高脂血症，代谢性酸痛，糖尿病，糖尿病性神经病和肾病。

    Methods for improving islet signaling in diabetes mellitus and for its prevention
    6.
    发明授权
    Methods for improving islet signaling in diabetes mellitus and for its prevention 失效
    改善糖尿病胰岛信号的方法及其预防

    公开(公告)号：US06890905B2

    公开(公告)日：2005-05-10

    申请号：US10216349

    申请日：2002-08-09

    申请人： Hans-Ulrich Demuth ,  Konrad Glund ,  Andrew J. Pospisilik ,  Kerstin Kuehn-Wache

    发明人： Hans-Ulrich Demuth ,  Konrad Glund ,  Andrew J. Pospisilik ,  Kerstin Kuehn-Wache

    IPC分类号： A61K31/40 ,  A61K31/426 ,  A61K38/00 ,  A61K31/425 ,  A61K31/70

    CPC分类号： A61K31/40 ,  A61K31/426

    摘要： The present invention discloses methods for therapeutically treating mammals, including but not limited to humans, to increase the relative insulin producing performance of endogenous pancreatic β-cells, to cause differentiation of pancreatic epithelial cells into insulin producing β-cells, to improve muscle sensitivity to insulin and other weight control efforts by the chronic oral administration of a DP IV-inhibitor. The administration causes the active form of GLP-1 and other non-nutrient stimulated growth hormones to remain biologically active longer under physiological conditions. The extended presence of such hormones, in particular in the pancreatic tissue can also facilitate differentiation and regeneration of the β-cells already present that are in need of repair.

    摘要翻译： 本发明公开了用于治疗性治疗哺乳动物（包括但不限于人）的方法，以增加内源性胰腺β-细胞的相对胰岛素产生性能，使胰腺上皮细胞分化为产生胰岛素的β细胞，以改善肌肉对 胰岛素和其他体重控制努力通过慢性口服给予DP IV抑制剂。 在生理条件下，给药导致GLP-1和其他非营养刺激生长激素的活性形式在生物活性更长的时间内保持生物活性。 这种激素，特别是胰腺组织的延长存在也可促进已经存在的需要修复的β细胞的分化和再生。

    Methods for improving islet signaling in diabetes mellitus and for its prevention
    9.
    发明申请
    Methods for improving islet signaling in diabetes mellitus and for its prevention 审中-公开
    改善糖尿病胰岛信号的方法及其预防

    公开(公告)号：US20070293426A1

    公开(公告)日：2007-12-20

    申请号：US11069544

    申请日：2005-03-01

    申请人： Hans-Ulrich Demuth ,  Konrad Glund ,  J. Pospisilik ,  Kerstin Kuehn-Wache

    发明人： Hans-Ulrich Demuth ,  Konrad Glund ,  J. Pospisilik ,  Kerstin Kuehn-Wache

    IPC分类号： A61K38/22 ,  A61P3/04

    CPC分类号： A61K47/26 ,  A61K31/426

    摘要： The present invention discloses methods for therapeutically treating mammals, including but not limited to humans, to increase the relative insulin producing performance of endogenous pancreatic β-cells, to cause differentiation of pancreatic epithelial cells into insulin producing β-cells, to improve muscle sensitivity to insulin and other weight control efforts by the chronic oral administration of a DP IV-inhibitor. The administration causes the active form of GLP-1 and other non-nutrient stimulated growth hormones to remain biologically active longer under physiological conditions. The extended presence of such hormones, in particular in the pancreatic tissue can also facilitate differentiation and regeneration of the β-cells already present that are in need of repair.

    摘要翻译： 本发明公开了用于治疗性治疗哺乳动物（包括但不限于人）的方法，以增加内源性胰腺β-细胞的相对胰岛素产生性能，使胰腺上皮细胞分化为产生胰岛素的β细胞，以改善肌肉对 胰岛素和其他体重控制努力通过慢性口服给予DP IV抑制剂。 在生理条件下，给药导致GLP-1和其他非营养刺激生长激素的活性形式在生物活性更长的时间内保持生物活性。 这种激素，特别是胰腺组织的延长存在也可促进已经存在的需要修复的β细胞的分化和再生。